BiotechTube

Bacterial Lysates + placebo

ApprovedCompleted
0 views this week 0 watching⚡ Active
Interest: 43/100
43
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Respiratory Tract Infections

Conditions

Respiratory Tract Infections

Trial Timeline

Dec 1, 2007 → Sep 1, 2008

NCT ID
NCT00599417

About Bacterial Lysates + placebo

Bacterial Lysates + placebo is a approved stage product being developed by Sanofi for Respiratory Tract Infections. The current trial status is completed. This product is registered under clinical trial identifier NCT00599417. Target conditions include Respiratory Tract Infections.

What happened to similar drugs?

9 of 20 similar drugs in Respiratory Tract Infections were approved

Approved (9) Terminated (3) Active (10)
✅Zopapogene imadenovec (Zopa)PrecigenApproved
✅YMC026 + PlaceboYuhanApproved
✅Montelukast + PlaceboMerckApproved
✅Sugammadex 100 MG/ML [Bridion]MerckApproved
✅diclofenac potassium + nimesulideNovartisApproved
✅Telithromycin + AzithromycinSanofiApproved
✅telithromycinSanofiApproved

Hype Score Breakdown

Clinical
20
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT00599417ApprovedCompleted

Competing Products

20 competing products in Respiratory Tract Infections

See all competitors
ProductCompanyStageHype Score
mRNA-1273ModernaPhase 1
0
mRNA-1345ModernaPhase 3
0
mRNA-1345ModernaPhase 1
0
mRNA-1345ModernaPhase 2
0
mRNA-1345ModernaPhase 2
0
mRNA-1345ModernaPhase 3
0
mRNA-1345ModernaPhase 3
0
mRNA-1345ModernaPreclinical
0
mRNA-1345ModernaPhase 3
0
mRNA-1345ModernaPhase 3
0
mRNA-1345ModernaPhase 1
0
Zopapogene imadenovec (Zopa)PrecigenApproved
44
PRGN-2012 - Phase I; Dose Level 1 + PRGN-2012 - Phase I; Dose Level 2 + PRGN-2012 - Phase II; Dose Level 2PrecigenPhase 1/2
30
agenT-797MiNK TherapeuticsPhase 1
19
YMC026 + PlaceboYuhanApproved
43
VN-0200 + PlaceboDaiichi SankyoPhase 1
29
VN-0200Daiichi SankyoPhase 2
35
Isavuconazonium Injection [Cresemba] + PlaceboAstellas PharmaPhase 3
32
S-337395 + PlaceboShionogiPhase 2
42
SivelestatEli LillyPhase 1/2
32